Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3742424014 | Product containing only pyrazinamide in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3742425010 | Pyrazinamide only product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pyrazinamide only product in oral dose form | Has active ingredient | Pyrazinamide | true | Inferred relationship | Some | 1 | |
| Pyrazinamide only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Pyrazinamide only product in oral dose form | Is a | Pyrazinamide only product | true | Inferred relationship | Some | ||
| Pyrazinamide only product in oral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Pyrazinamide only product in oral dose form | Is a | Pyrazinamide-containing product in oral dose form | true | Inferred relationship | Some | ||
| Pyrazinamide only product in oral dose form | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Pyrazinamide 500 mg oral tablet | Is a | True | Pyrazinamide only product in oral dose form | Inferred relationship | Some | |
| Pyrazinamide 400 mg oral tablet | Is a | True | Pyrazinamide only product in oral dose form | Inferred relationship | Some | |
| Pyrazinamide 150 mg tablet for oral suspension | Is a | True | Pyrazinamide only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR